Catalase

NutraPedia - Evidence-Based Supplement Research

Back to Table of Contents
Health Goals: detox longevity immunity

Research Overview

Across the abstracts, catalase (CAT) research is most concentrated in oxidative-stress biology and disease relevance, with emphasis on CAT’s core enzymatic role in decomposing hydrogen peroxide into water and oxygen and thereby limiting oxidative damage to DNA, proteins, and lipids. A major theme is the association between reduced CAT activity (deficiency, malfunction, or modification) and age-associated or chronic disorders, including metabolic and neurodegenerative diseases (e.g., diabetes mellitus, Alzheimer’s and Parkinson’s diseases), pigmentary disorders (vitiligo), and broader degenerative or inflammatory conditions. A second heavily studied area is therapeutic leveraging of CAT—either as a protein therapeutic or as part of combination strategies and delivery platforms—illustrated by work combining CAT with antioxidants such as curcumin for knee osteoarthritis and by nanotechnology approaches (e.g., MOF-based encapsulation systems) designed to localize catalytic activity and modulate oxygen/ROS chemistry in pathological microenvironments (including hypoxic tumors). Nutritional and functional-food contexts are also prominent, where interventions (e.g., Spirulina, honey, alternative aquaculture feeds, and oral antioxidant enzyme supplements) are evaluated for their ability to increase endogenous antioxidant enzyme activities, including CAT.

The strongest evidence supported by these abstracts is that CAT is a central component of antioxidant defense and that increasing CAT activity—directly (exogenous CAT) or indirectly (upregulating endogenous CAT alongside other antioxidant enzymes)—is consistently associated with reduced oxidative-stress markers and improved cellular or tissue outcomes in experimental models. Mechanistic work in osteoarthritis provides a representative example: curcumin-driven activation of NRF2/HO-1 appears to enhance upstream antioxidant capacity, while CAT specifically removes downstream hydrogen peroxide, together reducing ROS burden and apoptosis in chondrocytes and improving oxidative-stress–related injury in vivo. In parallel, multiple intervention-oriented studies (nutraceuticals, dietary ingredients, enzyme supplements) converge on the observation that CAT activity often rises alongside other antioxidant defenses (e.g., superoxide dismutase, glutathione-related systems) and correlates with improved physiological or inflammatory readouts, supporting CAT as a robust biomarker and plausible mediator within broader redox-regulatory networks.

Key gaps remain in translating these findings into standardized, clinically actionable therapies. The abstracts highlight needs for (i) larger, well-controlled human trials to establish efficacy, dosing, and safety for CAT-targeting interventions (including functional foods and enzyme supplementation), (ii) clearer causal attribution of benefits specifically to CAT versus correlated changes in other antioxidant pathways, and (iii) deeper mechanistic resolution of how complex mixtures (e.g., Spirulina constituents, honey bioactives) regulate CAT expression/activity and where threshold or tapering effects arise. For CAT as a therapeutic protein or nanomedicine component, additional research is needed on delivery efficiency, stability, immunogenicity, tissue targeting, and pharmacokinetics/pharmacodynamics, as well as disease-specific optimization (e.g., tumor hypoxia modulation versus inflammatory degeneration). Finally, heterogeneity in composition (noted for honey) and species-specific responses (noted for aquaculture) underscores the need for standardization, comparative studies, and reproducibility-focused designs.

1. What conditions has Catalase been studied for?

  • Age-associated and degenerative diseases linked to oxidative stress (association/deficiency focus): diabetes mellitus, hypertension, anemia, vitiligo, Alzheimer’s disease, Parkinson’s disease, bipolar disorder, cancer, and schizophrenia (described as conditions where catalase deficiency/malfunction is postulated to contribute to pathogenesis).

  • Knee osteoarthritis (KOA): studied as a therapeutic enzyme (catalase) in combination with curcumin to reduce oxidative stress and chondrocyte injury.

  • COVID-19 (SARS-CoV-2 infection): catalase-based therapeutic evaluated in human leukocytes and alveolar epithelial cells and in rhesus macaques.

  • Parkinson’s disease (delivery-focused): catalase delivered via extracellular vesicles in pre-clinical models to reduce oxidative stress and support neuronal survival.

  • Cancer therapy support (tumor hypoxia/radiotherapy resistance): catalase-like oxygenation strategies and catalase-containing nanomaterials/MOF systems are described to modulate hydrogen peroxide and oxygen in tumors (platform/strategy-level evidence in the abstracts provided).

  • General oxidative stress and inflammation models: multiple abstracts discuss catalase as a key antioxidant enzyme that decomposes hydrogen peroxide; several nutrition/supplement contexts (e.g., Spirulina, honey, Montmorency cherry concentrate) report changes in catalase activity as part of broader antioxidant responses.

2. Does it work in treating those conditions? Summarize the evidence.

  • Knee osteoarthritis (KOA): One abstract reports that curcumin + catalase inhibited IL-1β–induced chondrocyte apoptosis in vitro without cytotoxicity and improved oxidative-stress–related outcomes in vivo (animal model). Mechanistically, the combination enhanced antioxidant defenses via NRF2/HO-1 pathway effects (curcumin) plus catalase removal of downstream hydrogen peroxide. This supports potential efficacy, but it is not a human clinical trial.

  • COVID-19: A catalase-based therapeutic is reported to regulate cytokine production, protect against oxidative injury, and repress SARS-CoV-2 replication in human leukocytes and alveolar epithelial cells and in rhesus macaques, with no noticeable toxicity in that report. This is promising preclinical/animal evidence; it does not establish efficacy in large human randomized trials.

  • Parkinson’s disease: An extracellular vesicle delivery review cites pre-clinical models where catalase delivery reduced oxidative stress and helped neurons survive. This is supportive but indirect (review-level summary) and not evidence of clinical benefit in humans.

  • Broader degenerative diseases (diabetes, Alzheimer’s, vitiligo, etc.): One abstract emphasizes that catalase deficiency/malfunction is postulated to be involved in pathogenesis and that efforts are underway to explore catalase as a protein therapeutic. However, within the provided abstracts, direct clinical efficacy evidence for catalase treatment in these diseases is not established.

  • Cancer hypoxia/radiotherapy resistance: The abstracts describe catalytic oxygenation/nanohybrid strategies involving catalase-like activity or catalase incorporation to modulate tumor oxygenation and hydrogen peroxide. These are platform concepts and preclinical directions; the provided text does not give definitive clinical outcome data.

  • Dietary supplements that increase catalase activity (indirect evidence): Spirulina is described as increasing catalase activity (with a noted threshold beyond which antioxidant activity tapers), and Montmorency cherry concentrate altered several antioxidant genes/proteins but did not show significant changes for catalase specifically in that trial. These findings support catalase as a biomarker/part of antioxidant response, but they are not the same as demonstrating that oral catalase itself treats disease.

Overall, the strongest “works as a treatment” signals in the provided abstracts are preclinical: KOA (combination therapy), COVID-19 (cells + rhesus macaques), and Parkinson’s disease (preclinical delivery). Human clinical efficacy for catalase as a standalone supplement/drug is not established in these abstracts.

3. What health benefits does it have?

  • Core biochemical benefit: Catalase decomposes hydrogen peroxide into water and oxygen, helping mitigate oxidative stress (multiple abstracts emphasize catalase as a “paramount”/crucial enzymatic antioxidant).

  • Potential anti-inflammatory and cytoprotective effects via oxidative stress reduction: In KOA models, catalase (with curcumin) reduced oxidative-stress–induced chondrocyte injury and apoptosis; in COVID-19 models, catalase therapy was reported to regulate cytokines and protect against oxidative injury.

  • Potential support for conditions where catalase deficiency is implicated: One abstract links catalase deficiency/malfunction to multiple age-associated diseases (e.g., diabetes, neurodegeneration, vitiligo), suggesting a rationale for therapeutic exploration, though benefit depends on successful delivery and clinical validation.

  • Functional food/supplement contexts (indirect): Spirulina is described as increasing catalase activity and reducing oxidative damage markers; honey contains enzymes including catalase among many antioxidant components and is discussed as having broad antioxidant-related health effects (cardiovascular protection, anti-inflammatory effects, wound healing), though these benefits cannot be attributed to catalase alone based on the abstract.

4. Does it have any downsides or side effects?

  • Safety signals in the provided abstracts: The COVID-19 catalase therapeutic report states no noticeable toxicity in the described models (human cells and rhesus macaques). The KOA study reports the curcumin+catalase combination inhibited apoptosis without cytotoxicity in vitro.

  • Limitations/unknowns: The abstracts do not provide comprehensive adverse event profiles, dosing ranges, or long-term safety data in humans for catalase as a drug or dietary supplement. Protein therapeutics can have practical issues (e.g., stability, delivery to target tissues, immunogenicity), but these specific risks are not detailed in the provided abstracts.

  • “Too much antioxidant” considerations (indirect): The Spirulina review notes a threshold above which antioxidant activity tapers off. This does not prove harm from higher dosing, but it suggests diminishing returns and highlights that antioxidant modulation is not always linear.

Based strictly on the provided abstracts, catalase appears well-tolerated in the cited preclinical contexts, but human side-effect data are insufficient here to draw firm conclusions.

5. Is it beneficial or harmful for any genetic variations (pharmacogenomics)?

  • Acatalasemia (catalase deficiency): One abstract explicitly discusses catalase deficiency/malfunction and mentions acatalasemia, implying that individuals with genetic catalase deficiency could be a biologically plausible group to benefit from catalase-targeted strategies. However, the abstract does not provide genotype-stratified treatment outcomes.

  • Other genetic variation claims: The provided abstracts do not report specific catalase gene (CAT) polymorphisms, responder/non-responder data, dosing adjustments, or adverse effects tied to genetic variants.

In summary, the abstracts support a rationale that catalase deficiency states (including acatalasemia) are relevant, but they do not provide direct pharmacogenomic evidence showing who benefits or is harmed from catalase therapy based on genotype.

References

  1. Role of Catalase in Oxidative Stress- and Age-Associated Degenerative Diseases.
    Ankita Nandi, Liang-Jun Yan, Chandan Kumar Jana, Nilanjana Das (2019) - Oxidative medicine and cellular longevity
  2. Exploring Therapeutic Potential of Catalase: Strategies in Disease Prevention and Management.
    Shehwaz Anwar, Faris Alrumaihi, Tarique Sarwar, Ali Yousif Babiker, Amjad Ali Khan, Sitrarasu Vijaya Prabhu, Arshad Husain Rahmani (2024) - Biomolecules
  3. The antioxidant, immunomodulatory, and anti-inflammatory activities of Spirulina: an overview.
    Qinghua Wu, Lian Liu, Anca Miron, Blanka Klímová, Dan Wan, Kamil Kuča (2016) - Archives of toxicology
  4. Combination of curcumin and catalase protects against chondrocyte injury and knee osteoarthritis progression by suppressing oxidative stress.
    Bohao Chen, Qi He, Chuyi Chen, Yuewei Lin, Jiacong Xiao, Zhaofeng Pan, Miao Li, Shaocong Li, Junzheng Yang, FanChen Wang, Jiaxu Zeng, Yanzi Yi, Weijin Chi, Kai Meng, Haibin Wang, Peng Chen (2023) - Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
  5. A Catalase-Like Metal-Organic Framework Nanohybrid for O
    Zhimei He, Xiaolin Huang, Chen Wang, Xiangli Li, Yijing Liu, Zijian Zhou, Sheng Wang, Fuwu Zhang, Zhantong Wang, Orit Jacobson, Jun-Jie Zhu, Guocan Yu, Yunlu Dai, Xiaoyuan Chen (2019) - Angewandte Chemie (International ed. in English)
  6. Antioxidant Capacity and Therapeutic Applications of Honey: Health Benefits, Antimicrobial Activity and Food Processing Roles.
    Ivana Tlak Gajger, Showket Ahmad Dar, Mohamed Morsi M Ahmed, Magda M Aly, Josipa Vlainić (2025) - Antioxidants (Basel, Switzerland)
  7. Metal-Organic Framework (MOF) Hybrid as a Tandem Catalyst for Enhanced Therapy against Hypoxic Tumor Cells.
    Jintong Liu, Tianrui Liu, Ping Du, Lei Zhang, Jianping Lei (2019) - Angewandte Chemie (International ed. in English)
  8. Fish Responses to Alternative Feeding Ingredients under Abiotic Chronic Stress.
    Julieta Sánchez-Velázquez, Guillermo Abraham Peña-Herrejón, Humberto Aguirre-Becerra (2024) - Animals : an open access journal from MDPI
  9. Superoxide dismutase ameliorates oxidative stress and regulates liver transcriptomics to provide therapeutic benefits in hepatic inflammation.
    Longyan Chen, Yang Liu, Yonggang Zhang, Yanmin Zhang, Wei Wang, Hongyu Han, Chunyu Yang, Xueqian Dong (2023) - PeerJ
  10. An Antioxidant Enzyme Therapeutic for COVID-19.
    Meng Qin, Zheng Cao, Jing Wen, Qingsong Yu, Chaoyong Liu, Fang Wang, Jianjun Zhang, Fengmei Yang, Yanyan Li, Gregory Fishbein, Sen Yan, Bin Xu, Yi Hou, Zhenbo Ning, Kaili Nie, Ni Jiang, Zhen Liu, Jun Wu, Yanting Yu, Heng Li, Huiwen Zheng, Jing Li, Weihua Jin, Shen Pang, Shuai Wang, Jianfeng Chen, Zhihua Gan, Zhanlong He, Yunfeng Lu (2020) - Advanced materials (Deerfield Beach, Fla.)
  11. Protection against oxidative stress and anti-aging effect in Drosophila of royal jelly-collagen peptide.
    Wenjing Qiu, Xu Chen, Yongqi Tian, Daping Wu, Ming Du, Shaoyun Wang (2020) - Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association
  12. Tart Cherry Supplement Enhances Skeletal Muscle Glutathione Peroxidase Expression and Functional Recovery after Muscle Damage.
    Jimmy T Wangdi, Mary F O'Leary, Vincent G Kelly, Sarah R Jackman, Jonathan C Y Tang, John Dutton, Joanna L Bowtell (2022) - Medicine and science in sports and exercise
  13. Delivery of Therapeutic Proteins via Extracellular Vesicles: Review and Potential Treatments for Parkinson's Disease, Glioma, and Schwannoma.
    Justin Hall, Shilpa Prabhakar, Leonora Balaj, Charles P Lai, Richard A Cerione, Xandra O Breakefield (2016) - Cellular and molecular neurobiology
  14. Antioxidative Status and Meat Quality Traits as Affected by Dietary Supplementation of Finishing Pigs with Natural Phenolics.
    Małgorzata Muzolf-Panek, Anita Zaworska-Zakrzewska, Anna Czech, Dariusz Lisiak, Małgorzata Kasprowicz-Potocka (2024) - Antioxidants (Basel, Switzerland)
  15. Antioxidant Activity of Different Tissues from Rabbits Fed Dietary Bovine Colostrum Supplementation.
    Valentina Serra, Marta Castrica, Stella Agradi, Giulio Curone, Daniele Vigo, Alessia Di Giancamillo, Silvia Clotilde Modina, Federica Riva, Claudia Maria Balzaretti, Roberta De Bellis, Gabriele Brecchia, Grazia Pastorelli (2023) - Animals : an open access journal from MDPI
  16. Defect engineering to tailor structure-activity relationship in biodegradable nanozymes for tumor therapy by dual-channel death strategies.
    Yutian Su, Mengdi Lv, Zheng Huang, Nannan An, Yi Chen, Haoru Wang, Zhengtu Li, Shishan Wu, Feng Ye, Jian Shen, Ao Li (2024) - Journal of controlled release : official journal of the Controlled Release Society
  17. Photoinactivation of catalase sensitizes a wide range of bacteria to ROS-producing agents and immune cells.
    Pu-Ting Dong, Sebastian Jusuf, Jie Hui, Yuewei Zhan, Yifan Zhu, George Y Liu, Ji-Xin Cheng (2022) - JCI insight
  18. Reprograming Clots for In Vivo Chemical Targeting in Traumatic Brain Injury.
    Rebecca M Kandell, Jason R Wu, Ester J Kwon (2024) - Advanced materials (Deerfield Beach, Fla.)
  19. The Effect of SP/NK1R on the Expression and Activity of Catalase and Superoxide Dismutase in Glioblastoma Cancer Cells.
    Faranak Korfi, Hossein Javid, Reza Assaran Darban, Seyed Isaac Hashemy (2021) - Biochemistry research international


Want personalized supplement recommendations based on your genetics?
Upload Whole Genome Sequencing (WGS) raw DNA data today!
Or upload raw DNA data to get started with your free analysis!